Sartorius and Siemens: automating the biopharmaceutical industry

With Siemens now a preferred supplier, Sartorius’s product portfolio benefits from a globally standardised automation platform; Dr Kevin Robinson caught up with the two companies at ACHEMA 2018 to discuss their new agreement and the requirements of the biopharma industry

picture of

Breaking News

Univercells launches new vaccine manufacturing platform

Low-cost vaccine manufacturing technology, NevoLine, has been launched and already received grant for scale-up

Bio-Rad publishes new findings on Drug-Target Complex-Specific Antibodies

US laboratory has released findings on the Generation and Characterisation of Drug-Target Complex-Specific Antibodies

Cytoreason and Pfizer to use machine learning model of the immune system for drug discovery

CytoReason, a leader in machine learning for drug discovery and development, has entered into a collaboration agreement ...

Automating the production of life-saving drugs

Bosch Packaging Technology has developed a new integrated filling line for Porton Biopharma

Locate Bio is granted key US and EU patents for its IntraStem non-viral, next generation gene delivery technology

Locate Bio, a cell and gene therapy platform company developing a pipeline of regenerative medicine products, has ...

Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industry

Global industry shows confidence in cell and gene therapies and in UK’s ability to deliver these life-changing ...

Treating chronic wounds with live biotherapeutics

Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, ...

Stamp of approval for algae-based synthetic biology

The 4-year, EU-funded TriForC (Triterpene’s For Commercialisation) project has come to a close, resulting in the ...

Immuno-oncology drug development and personalised medicine will continue to reshape the pharma industry in 2019

Immuno-oncology (IO) drug development will remain at the forefront of the pharmaceutical industry in 2019, says ...

Realising the potential of single-use technology

Today’s growing pipeline of biological drugs require production environments that are agile and efficient, writes David ...

Performance validation: HPAPI containment testing in a risk-based era

Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, ...

Plant-based expression systems expedite time to market

Leaf Expression Systems is a new contract development business specialising in the plant-based expression and ...

Cell and Gene Therapy Catapult and pHion Therapeutics announce licencing agreement for RALA technology

Collaboration could reduce the cost of cell and gene therapy production by developing a more efficient method of ...

Eisai, BMS and H3 Biomedicine announce research collaboration

Bristol-Myers Squibb, Eisai and its US-based precision medicine research and development subsidiary H3 Biomedicine, ...